Genetic polymorphisms of low molecular weight prote in tyrosine phosphatase (LMW-PTP): Relations erythrocyte enzymatic phenotype in patients with Systemic Lupus Erythematosus;Polimorfismos genéticos da proteína tirosina fosfatase de baixo peso molecular [LMW-PTP]: Sua relação com o fenótipo enzimático eritrocitário em doentes com Lúpus Eritematoso Sistémico

Acta Reumatologica Portuguesa

Volumn 33, Issue 2, 2008, Pages 177-187

  Esteves Martins, Maria de Fátima Araújo ^a,d   Carvalho, Raquel ^b   Alves, Miguel ^c   da Silva Ferreira, Carlos Alberto Monteiro ^b   Pires Bicho, Manuel Diamantino ^b  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^b UNIVERSITY OF LISBON   (Portugal)

^c HOSPITAL DE SANTA MARIA   (Portugal)

^d Hospital de Santa Maria ^*  (Portugal)

Author keywords

ACP1; LMW PTP; Signal transduction; SLE

Indexed keywords

EID: 53749085850     PISSN: 0303464X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Tsao BP. The genetics of human systemic lupus erythematosus. Trends Immunol 2003;24:595-602.
2. Kewalramani, Singh AK. Immunopathogenesis of Lupus and Lupus Nephritis: recent insights. Curr Opin Nephrol Hypertens 2002;11:273-277.
3. Das Un. Oxidants and antioxidants, essencial fatty acids, eicosanoids, cytokines, gene/oncogenes expression and apoptosis in SLE. J Assoc Phys India 1998;46:630-634.
4. Tsokos, G.C. Overview of cellular immune function. In: R.G. Lahita, editor. Systemic lupus erythematosus. New York USA: Academic Press, 1998: 17-54.
5. Tsokos GC, Liossis SC. Immune cell signaling defects in lupus: activaction, anergy and death. Immunology Today 1999;20:119-124.
6. King PD. Lupus-like autoimmunity caused by defects in T-cell signal transduction. Curr Opin Investig Drugs 2004;5:517-23.
7. Cantley LCKR, Auger C, Carpenter B et al. Oncogenes and signal transduction. Cell 1991;64:281-302.
8. Bishop MJ. Molecular themes in oncogenesis. Cell 1991:64;235-248.
9. Bottini N, Bottini E, Gloria-Bottini F, Mustelin T. Low-molecular-weight protein tyrosine phosphatase and human disease: in search of biochemical mechanisms. Arch Immunol Exp (Warsz) 2002;50:95-104.
10. Blake NM, Kirk RL, Barnes KR, Thompson JM. Expression of human red cell acid phosphatase activity in placenta and other tissues. Jpn J Hum Genet 1973;18:10-23.
11. Boivin P, Galand C. The human red cell acid phosphatase is a phosphotyrosine protein phosphatase which dephosphorylates the membrane protein band 3. Biochem Biophys Res Commun 1986;134: 557-564.
12. Chiarugi P, Cirri P, Marra F et al. The Src and signal transduction pathways as specific targets for low molecular weight phosphotyrosine-protein phosphatase in platelet-derived growth factor signaling. J Biol Chem 1998;273:6776-6785.
13. Bucciantini M, Chiarugi P, Cirri P et al. The low Mr phosphotyrosine protein phosphatase behaves differently when phosphorylated at Tyr131 or Tyr132 by Src kinase". FEBS Lett 1999;456:73-78
14. Chiarugi P, Cirri P, Taddei L et al. The low Mr protein-tyrosine phosphatase is involved in Rho-mediated cytoskeleton rearrangement after integrin and platelet-derived growth factor stimulation. J Biol Chem 2000;275:4640-4646.
15. Taddei M, Chiarugi P, Cirri P et al. LMW-PTP exerts a differential regulation on PDGF - and insulin-mediated signaling. Biochem. Biophys Res Commun 2000;270:564-569.
16. Raugei G, Ramponi G, Chiarugi P. Low molecular weight protein tyrosine phosphatases: small but smart. Cell Mol Life Sci 2002;59:941-949.
17. Bottini E, Gloria-Bottini F, Borgiani P. ACP1 and human adaptability, 1: association with common diseases: a case-control study. Hum Genet 1995;96:629-37.
18. Bottini E, Bottini FG, Borgiani P, Businco L. Association between ACP1 and favism: a possible biochemical mechanism. Blood 1997;87:2613-2615.
19. Bottini N, Stefanini I, Williams S, et al. Activation of ZAP-70 trough specific dephosphorylation at the inhibitory Tyr-292 by low-molecular weight phosphotyrosine phosphatase (LMPTP). J Biol Chem 2002; 24220-24224.
20. Dissing J. Human "red cell" acid phosphatase (ACP1) genetic, catalytic and molecular properties. PhD Thesis, Kobenhavn Uiniversitat, Kobenhavn, Denmark. 1993.
21. Lazaruk KDA, Dissing J, Sensabaugh GF. Exon structure at the Human Acp1 locus supports alternative splicing model for f-isozyme and s-isozyme generation. Bichem Biophys Res Commun 1993;196:440-446.
22. Dissing J, Johnsen AH, Sensabaugh GF. Human red cell acid phosphatase (ACP1) - the amino acid sequence of the two isozymes Bf and Bs encoded by the ACP1*B allele. J Biol Chem 1991;266:20619-20625.
23. Ramponi G, Stefani M. Structure and function of the low Mr phosphotyrosine protein phosphatases. Biochim Biophys Acta 1997;1341:137-156.
24. Fuchs KR, Shekels LL, Bernlohr DA. Analysis of the ACP1 gene product - classification as an FMN phosphatase. Biochem Biophys Res Commun 1992;189:1598-1605.
25. Luffman JE, Harris H. A comparison of some properties of human red cell acid phosphatase in different phenotypes. Ann Hum Gent 1967;30:387-400.
26. Mansfield E, Sensabaugh GF. Red cell acid phosphatase: modulation of activities by purines. In: Brewer GJ ed. The Red Cell (vol.4). New York: Alan R Liss Inc., 1978:233-249.
27. Spencer N, Hopkinson DA, Harris H. Quantitative differences and gene dosage in the human red cell acid phosphatase polymorphism. Nature 1964;201: 299-300.
28. JenkinsT, Corfield V. The red cell acid phosphatase polymorphism in Southern Africa: population data and studies on the R, RA and RB phenotypes. Ann Hum Genet 1972;35:379-391.
29. Yoshihara CM, Mohrenweiser HW. Characterization of ACP1TIC-1, an electrophoretic variant of erythrocyte acid phosphatase restricted to the Ticuna Indians of Central Amazonas. Ann Hum Genet 1980;32:898-907.
30. Mohrenweiser H, Novotny JE. ACP1GUA-1_A low-activity variant of human erythrocyte acid phosphatase: association with increase glutathione reductase activity. Am J Hum Genet 1982;34:425-433.
31. Cavalli-Sforza LL, Menozzi P, Piazza A. In: NJ. Princeton University. The history and geography of human genes. Princeton: NJ. Princeton University Press, 1994.
32. Dissing J. In: Brinkman Band Henningsen K, eds. Advances in Forensic Haemogenetics Vol.1.Berlin: Springer-Verlag, Berlin, 1986:127-131.
33. Golden VL, Sensabaugh GF. Phenotypic variation in the phosphotranferase activity of human red cell acid phosphatase (ACP1). Hum Genet 1986;72:340-343.
34. Eze LC, Tweedie MCK, Bullen MF, Wren PJJ, Evans DAP. Quantitative genetics of human red cell acid phosphatase. Ann Hum Genet 1974;37:333.
35. Dissing J. Immunochemical characterization of human red cell acid phosphatase isozymes. Biochem Genet 1987;25:901-917.
36. Swallow DM, Povey S, Harris H. Activity of the "red cell" acid phosphatase locus in other tissues. Ann Hum Genet 1973;37:31-38.
37. Bryson GLM, Massa H, Trask BJ, Vanetten RL. Gene structure, sequence and chromosomal localization of the human red cell-type low-molecular-weight acid phosphotyrosyl phosphatase gene, ACP1. Genomics 1995;30:133-140.
38. Lazaruk KDA. PhD dissertation: Molecular genetics of human red cell acid phosphatase. Berkeley, Univ. of California, 1995.
39. Rudberk L, Dissing J, Lazaruk KDA, Sensabaugh G. Human 18KDa phosphotyrosine protein phosphatase (ACP1) polymorphism: studies of rare variants provide evidence that substitutions within or near alternative spliced exons affect splicing result. Ann Hum Gen 2000;64:107-116.
40. Rigacci S, Rovida E, Bagnoli S, Dello Sbarba P, Berti A. Low M(r) phosphotyrosine protein phosphatase activicty on fibroblast growth factor receptor is not associated with enzyne translocation. FEBS Lett 1999;459:191-194.
41. Stein E, Lane AA, Cerretti DP et al. Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses. Genes Dev 1998;12:667-678.
42. Rovida E, Rigacci S, Paccagnini A, Sbarba PD, Berti A. The-low-molecular-weight phosphotyrosine protein phosphatase, when overexpressed, reduces the mitogenic response to macrophage colony-stimulating factor and tyrosine phosphorylation of its receptor. Bichem Res Commun 1998;253:300-304.
43. Drabkin D L, Austin J H. Spectrophotometric studies: I Spectrophotometric constants for common hemoglobin derivatives in human, dog and rabbit blood. J Biol Chemistry 1932;98:719.
44. Marques E, Crespo ME, Silva ZI, Bicho M. Redox modulation of reductase and phosphatase activities in human erythrocytes. Protoplasma 1999;206:68-173.
45. Dissing J, Dahl O, Svensmark O. Phosphoric and arsonic acids as inhibitors of human red cell acid phosphatase and their use in affinity chromatography. Biochim Biophys Acta 1979;569:159-176.
46. Hay EM, Bacon PA, Gordon C et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. QJ Med 1993;86:447-458.
47. Isenberg DA, Gordon C. From BILAG to BLIPS - Disease activity assessment in Lupus: past, present and future. Lupus 2000;9:651-654.
48. Mok CC, Lau CS. Pathogenesis of Systemic Lupus erythematosus. J Clin Pathol 2003;56:481-90.
49. Chiarugi P, Cirri P, Raugei G et al. PDGF receptor as a specific in vivo target for low Mr phosphotyrosine protein phosphatases. FEBS Lett 1995;372:49-53.
50. Cirri P, Chairugi P, Taddei L et al. Low molecular weight protein-tyrosine phosphatase tyrosine phosphorylation by c-Src during platelet-derived growth factor-induced mitogenesis correlates with its subcellular targeting. J Biol Chem 1998;273:32522-32527.
51. Rigacci S, Rovida E, Dello Sbarba P, Berti A. Low Mr Phosphotyrosine protein phosphatase associates and dephosphorylates p125-focal adhesion kinase, interfering with cell motility and spreading. J Biol Vhem 2002;277:41631-41636.
52. Caselli A, Taddei ML, Manao G, Camici G, Ramponi G. Tyrosine phosphorylate caveolin is a physiological substrate of the low Mr protein-tyrosine phosphatases. J Biol Chem 2001;276:18849-18854.
53. Parri M, Burichi F, Taddei ML et al. Ephrin A1 repulsive response is regulated by an EphA2 tyrosine phosphatase. J Biol Chem 2005;280:34008-34018.
54. Caselli A, Camici G, Manao G et al. Nitric oxide causes inactivation of the low molecular weight phosphotyrosine protein phosphatases. J Biol Chem 1994;269:24878-24882.
55. Caselli A, Marzocchini R, Camici G et al. The inactivation mechanism of low molecular weight phosphotyrosine protein phosphatase by H2O2. J Biol Chem 1998;273:32554-32560.
56. Kamata H, Hirata H. Redox regulation of cellular signalling. Cell Signal 1999;11:1-14.
57. Denu JM, Tanner KG. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry 1998;37:5633-5642.
58. Hecht D, Zick Y. Selective inhibition of protein tyrosine phosphatase activities by H2O2 and vanadate in vitro. Biochem Biophys Res Commun 1992;188:773-779.437:263-266.